Imagene AI
PrivateLast Round
Series B
Jul 1, 2025
Total Funding Raised
$44.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Imagene AI operates in Healthcare & Life Sciences and is based in Tel Aviv. Its latest recorded funding round was a Series B round in July 2025.
Imagene AI is a healthtech company that develops an AI-powered software platform for precision oncology, utilizing multimodal foundation models to analyze biopsy images for biomarker detection and clinical trial optimization.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Drug Discovery, Medical AI, Medical Imaging, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Imagene AI Comparables
Compare Imagene AI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nucleai | 86% | |
| Panakeia | 86% | |
| Aignostics | 81% |
For institutional investors. Book with your work email.
Imagene AI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 1, 2025 | ||||
| Seed | May 2, 2022 | ||||
| Series A | May 2, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Imagene AI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Blumberg Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 374% MoM, reaching 10.8K.
- Jul 1, 2025
$23M round led by Larry Ellison.
For institutional investors. Book with your work email.
Imagene AI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Imagene AI's valuation, stock price, and market status.
Is Imagene AI a public or private company?
Imagene AI is a private company.
What is the current stock price of Imagene AI?
Imagene AI is a private company, so its shares have no public market price. Caplight tracks Imagene AI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Imagene AI worth (valuation)?
Valuation information for Imagene AI is not publicly available.
Can I buy Imagene AI stock?
Imagene AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Imagene AI's last funding round?
Imagene AI's most recent funding round was Series B on July 1, 2025.
Who are the main investors in Imagene AI?
Key investors in Imagene AI include Blumberg Capital.
Will Imagene AI IPO soon?
No public IPO plans have been announced for Imagene AI.
How can I track Imagene AI secondary market activity?
Caplight tracks bids, offers, and trades in Imagene AI's shares on secondary markets.